Rare lung diseases
We're improving diagnosis and developing new treatments for rare lung diseases like primary ciliary dyskinesia, cystic fibrosis and idiopathic pulmonary fibrosis.
Key investigator: Prof Jane Lucas
Prof Jane Lucas leads our research into rare lung diseases, to improve diagnosis, enable better disease management and develop new treatments.
Read full profile
Primary ciliary dyskinesia
Professor Jane Lucas
Primary ciliary dyskinesia (PCD) hinders the clearance of mucus, bacteria and debris from the lungs, increasing chances of infection. We conduct long-term research into how PCD progresses in both children and adults, and improving PCD diagnosis and treatment.
Dr Mary Carroll
Our focus is on understanding and improving antibiotic treatment of lung infections in cystic fibrosis, and the psychological impact the condition has on patients and their caregivers.
Interstitial lung disease
Dr Sophie Fletcher and Dr Mark Jones
Interstitial lung disease (ILD) is a group of diseases that cause scarring (fibrosis) of the lungs. We’re developing new patient-specific treatments and methods of diagnosis.